Is there a role for ovarian function suppression in operable breast cancer?

被引：0
|
作者：
Joseph A. Sparano
机构：
[1] Albert Einstein College of Medicine,
[2] Montefiore Medical Center,undefined
来源：
Breast Cancer Research and Treatment | 2010年 / 123卷
关键词：
Breast Cancer; Tamoxifen; Premenopausal Woman; Exemestane; Operable Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 313
页数：2
相关论文
共 50 条
  • [21] The curative role of radiotherapy in the treatment of operable breast cancer
    Kurtz, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (15) : 1961 - 1974
  • [22] The Evolving Role of Neoadjuvant Therapy for Operable Breast Cancer
    Spring, Laura M.
    Bar, Yael
    Isakoff, Steven J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 723 - 734
  • [23] Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
    Montemurro, Filippo
    Perrone, Francesco
    Geuna, Elena
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (17): : 1672 - 1673
  • [24] Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
    Amoroso, Vito
    Berruti, Alfredo
    Simoncini, Edda
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (14): : 1357 - 1357
  • [25] Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
    Francis, Prudence A.
    Regan, Meredith M.
    Fleming, Gini F.
    Lang, Istvan
    Ciruelos, Eva
    Bellet, Meritxell
    Bonnefoi, Herve R.
    Climent, Miguel A.
    Da Prada, Gian Antonio
    Burstein, Harold J.
    Martino, Silvana
    Davidson, Nancy E.
    Geyer, Charles E., Jr.
    Walley, Barbara A.
    Coleman, Robert
    Kerbrat, Pierre
    Buchholz, Stefan
    Ingle, James N.
    Winer, Eric P.
    Rabaglio-Poretti, Manuela
    Maibach, Rudolf
    Ruepp, Barbara
    Giobbie-Hurder, Anita
    Price, Karen N.
    Colleoni, Marco
    Viale, Giuseppe
    Coates, Alan S.
    Goldhirsch, Aron
    Gelber, Richard D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (05): : 436 - 446
  • [26] Operable breast cancer
    Cianfrocca M.
    Goldstein L.J.
    Current Treatment Options in Oncology, 2001, 2 (2) : 157 - 167
  • [27] Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
    Bartsch, Rupert
    Bago-Horvath, Zsuzsanna
    Berghoff, Anna
    DeVries, Catharina
    Pluschnig, Ursula
    Dubsky, Peter
    Rudas, Margaretha
    Mader, Robert M.
    Rottenfusser, Andrea
    Fitzal, Florian
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 1932 - 1938
  • [28] Depression and anxiety after adjuvant ovarian function suppression in premenopausal breast cancer patients
    Yi, H. W.
    Nam, S. J.
    Kim, S. W.
    Lee, J. E.
    Lee, S. K.
    Bae, S. Y.
    Park, S.
    Paik, H-J
    Ryu, J. M.
    CANCER RESEARCH, 2016, 76
  • [29] Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Breast Cancer
    Basmadjian, Robert B.
    Lupichuk, Sasha
    Xu, Yuan
    Quan, May Lynn
    Cheung, Winson Y.
    Brenner, Darren R.
    JAMA NETWORK OPEN, 2024, 7 (03) : E242082
  • [30] Ovarian ablation by radiotherapy; is it still an option for the ovarian function suppression in endocrine responsive premenopausal breast cancer patients?
    Bese, N. S.
    Iribas, A.
    Oksuz, D. C.
    Atkovar, G.
    Ober, A.
    CANCER RESEARCH, 2009, 69 (02) : 341S - 341S
12345